medical news from internet
Friday, May 15, 2020
COVID-19: NIH Trial of Remdesivir Plus Baricitinib; Diagnostics Update
COVID-19: NIH Trial of Remdesivir Plus Baricitinib; Diagnostics Update
Inbox
x
MPR Daily Dose
<
editor@email.empr.com
>
Unsubscribe
Thu, May 14, 3:02 AM (1 day ago)
to
me
If you are having trouble viewing this email,
click here.
MUST READS
NIH Trial Evaluating Remdesivir Plus Baricitinib for COVID-19 Initiated
COVID-19 Diagnostics Update: First Antigen Test, New At-Home Saliva Collection Kit
INOpulse Inhaled Nitric Oxide to Be Assessed for COVID-19 in Phase 3 Study
Greater Reductions in HbA1c, Weight Observed With Higher Dulaglutide Dose
Aristada, Vivitrol Access Expanded During COVID-19 Pandemic
Clinical Chart
Diabetes Treatments
COVID-19 Resource Center
CME/CE Spotlight
Improved Outcomes for Naïve & Heavily Treatment—Experienced HIV Patients
AMA PRA Category 1 Credit(s)
TM
, CE for Pharmacists
CLICK HERE
FOR A FULL LIST OF COURSES
CE/CME Powered By myCME
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment